CD274 and neoplasm: Meanwhile, the mild PTT can activate the systemic immune response to increase the tumor infiltration of T cells and upregulate the expression of PD-L1 on the surface of tumor cells, which is expected to effectively remodel the TME and sensitize tumors to ICB therapeutic immune response.